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• Repeated  blast  exposures  causes  acute  decrease  in  GFAP  and  Tau  in brain  and  plasma.
• GFAP  and  Tau  levels  increases  acutely  in  the  liver  and spleen  after  blast  exposure.
• No  acute  changes  in  GFAP  and  Tau  mRNA  levels  in the  liver  after  blast  exposure.
• The  acute  changes  in  GFAP  and  Tau  suggest  blast-induced  cell  membrane  disruption.
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a  b  s  t  r  a  c  t
Glial  fibrillary  acidic  protein  (GFAP),  a protein  enriched  in  astrocytes,  and  Tau,  a protein  abundant  in
neuronal  microtubules,  are  being  widely  studied  as  biomarkers  of  brain  injury,  and  persistent  severity-
dependent  increases  in  brain  and  blood  have been  reported.  Studies  on  the  acute  changes  of these  proteins
after  blast  exposure  are  limited.  Using  a mouse  model  of closely-coupled  repeated  blast  exposures,  we
have evaluated  acute  changes  in  the levels  of  GFAP  and  total Tau  by  Western  blotting.  Brain  levels of GFAP
and  Tau  proteins  decreased  significantly  at 6  h and  increased  considerably  at  24 h  after  repeated  blast
exposures.  Plasma  samples  showed  a similar  initial  decrease  and  later  increase  over  this  timeframe.  This
biphasic  pattern  points  to possible  absorption  or sequestration  of  these  proteins  from  plasma  immedi-
ately  after  repeated  blast  exposures.  Liver  and  spleen  tissue  showed  significant  increases  in the  levels
of  GFAP  and  Tau  protein  at 6 and  24  h  post-blast  exposures  whereas  semi-quantitative  RT-PCR  analysis
of  liver  showed  no significant  changes  in the  levels  of GFAP  or Tau mRNAs.  These  results  suggest  that
blast  exposure  causes  transient  changes  in cell membrane  integrity  in  multiple  organs  leading  to  abnor-
mal  migration  of proteins  from  the  tissues  to  the  plasma  and  vice  versa.  This  transient  changes  in  cell
membrane  permeability  and  subsequent  bidirectional  movement  of molecules  may  contribute  to  the
pathophysiology  of TBI  and  polytrauma  after  blast  exposure.
© 2013 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
The incidence of traumatic brain injury (TBI) increased tremen-
dously during the recent wars and exposure to blast from
improvised explosive devices has been reported as the major cause
Abbreviations: TBI, traumatic brain injury; GFAP, glial fibrillary acidic protein;
BOP,  blast overpressure; CSF, cerebrospinal fluid; mRNA, messenger ribonucleic
acid; RT-PCR, reverse transcription-polymerase chain reaction.
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of battlefield TBI and associated disabilities in service members
[14]. One of the major differences between blast-induced TBI and
other closed head or penetrating brain injuries is that blast expo-
sure concomitantly injures other organs of the body, especially air
filled organs, resulting in polytrauma. Military personnel are sub-
ject to both high intensity single or low intensity repeated blast
exposures, and we have previously reported that the severity of
brain injury increases with number of blast exposures [27].
Identification of sensitive and specific biomarkers of TBI is
potentially useful for the diagnosis of injury and evaluation of
the efficacy of therapies. Although no biomarkers unique to blast-
induced TBI have been reported in clinical or pre-clinical blast
exposure studies to date, several brain proteins that are being
0304-3940/$ – see front matter ©  2013 Elsevier Ireland Ltd. All rights reserved.
http://dx.doi.org/10.1016/j.neulet.2013.07.047
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widely evaluated as biomarkers of other forms of brain injury have
also been considered as biomarkers of blast TBI. Notably, glial fib-
rillary acidic protein (GFAP), a protein enriched in astrocytes, and
Tau, a protein abundant in neuronal microtubules has been mon-
itored after various forms of brain injury including blast-induced
TBI [4,7,10,22,24,25].
Changes in blood and cerebrospinal fluid (CSF) levels of GFAP
have been widely studied as sensitive biomarkers for the diagnosis
TBI in humans [5,9,13,19,21,26,28] and significant up-regulation of
GFAP levels in multiple regions of the brain has also been reported
at different intervals after blast exposure in animal models of blast-
induced TBI [4,7,10,24]. In all these pre-clinical studies, the changes
in GFAP were evaluated after 24 h post-exposure. Changes in GFAP
levels in the brain or body fluids immediately after single blast
exposure have not been well documented. Besides, there are no
studies addressing the effects on GFAP levels in the brain or blood
after repeated blast exposures.
Apart from GFAP, up-regulation of total and phosphorylated
Tau proteins have also been shown in the brain, CSF and blood
of patients with different forms of TBI, and hence these proteins
have been proposed as reliable biomarkers of outcome after TBI
[11,15,20,23]. Total and phosphorylated Tau proteins in the brain
were significantly increased in different animal models of TBI
[7,11,22,25]. Limited studies have been carried out to assess the
changes in total or phosphorylated Tau proteins in the brain or
body fluids after blast exposure and there are no such studies
after repeated blast exposures. Similar to studies evaluated GFAP
levels, the differential expression of Tau protein was  determined
only at 24 h or later in single blast exposure and no studies so far
investigated the acute changes in Tau proteins after repeated blast
exposures.
In the present study, we assessed immediate changes in GFAP
and total Tau protein in the brains and plasma of mice after closely
coupled repeated blast overpressure exposures in a shock tube as
described earlier [27]. Western blotting with specific antibodies
was used to assess the levels of these potential blast injury biomark-
ers. Our results after repeated blast exposures showed an initial
decrease and later increase in the levels of both GFAP and total Tau
proteins in the brain and plasma. We  further explored the potential
mechanism of the contrasting changes in the two biomarkers of TBI
after repeated blast exposures.
2. Materials and methods
2.1. Animals and blast exposures
All animal experiments were conducted in accordance with the
Animal Welfare Act and other federal statutes and regulations relat-
ing to animals and experiments involving animals and adhered to
principles stated in the Guide for the Care and Use of Laboratory
Animals (NRC Publication 1996 edition). The animal protocol was
approved by Institutional Animal Care and Use Committee, Walter
Reed Army Institute of Research. C57BL/6J male mice (8–10 weeks
old) that weighed between 21 and 26 g (Jackson Laboratory, Bar
Harbor, ME)  were used in this study. A compressed air-driven shock
tube described earlier [12,27] was used for repeated blast expo-
sures. Mice were anesthetized with 4% isoflurane gas (O2 flow rate
1.5 L/min) for 8 min  and restrained in the prone position with a
tautly-drawn net to minimize the movements during blast expo-
sure. Animals were subjected to three blast overpressure (BOP)
exposures (21 psi) separated by 1 and 30 min  as described ear-
lier [28]. Blood plasma, brain, liver and spleen were collected after
euthanasia at 6 or 24 h post-blast and frozen immediately. Cere-
bellum, which showed significant injury after blast exposure in
previous studies [27] was dissected out immediately before freez-
ing the brain.
2.2. Western blot analysis of tissue homogenates
Tissue homogenates (20%, w/v) were prepared in tissue pro-
tein extraction buffer (Pierce Chemical Co., Rockford, IL) containing
protease and phosphatase inhibitor cocktails (Sigma–Aldrich, St.
Louis, MO)  using an ultrasonic homogenizer. The homogenates
were centrifuged at 5000 × g for 5 min  at 4 ◦C and 2 l each of
supernatants were used for Western blotting. Rabbit polyclonal
antibodies against GFAP and total Tau protein were obtained from
Abcam (Cambridge, MA)  and Santa Cruz Biotechnologies (Santa
Cruz, CA), respectively. GFAP antibody was  used at a dilution of
1:40,000 and an antibody to total Tau proteins was used at 1:1000
dilution. Secondary antibody labeled with horse-radish peroxidase
(HRP) was also purchased from Santa Cruz Biotechnology and used
at a dilution of 1:2500. A mouse monoclonal antibody to -actin
conjugated with HRP (Sigma–Aldrich, St. Louis, MO)  was used as gel
loading control at a dilution of 1:40,000. SDS–polyacrylamide gel
electrophoresis and Western blotting analysis of protein extracts
from cerebellum, liver and spleen was carried out as described ear-
lier [3]. After Western blotting, the protein bands were detected
using ECL-Plus Western blot detection reagent (GE Healthcare,
Piscataway, NJ) and the chemiluminescence was imaged in an
AlphaImage reader (Cell Biosciences, Santa Clara, CA). The band
intensity was  measured by densitometry using AlphaView software
(Cell Biosciences, Santa Clara, CA).
2.3. Western blotting of GFAP and tau proteins in the plasma
Plasma was  purified by removing albumins and globulins using
ProteoExtract Albumin/IgG removal kit from EMD-Millipore Cor-
poration (Chicago, IL) according to manufacturer’s instructions.
Briefly, 850 l of binding buffer was  allowed to pass through the
column by gravity-flow. Plasma (35 l) was diluted 10-fold with
binding buffer, allowed to pass through the column and the flow-
through was collected. The unbound proteins were also collected
by passing 650 l of binding buffer though the column twice. The
collected flow-through fractions were pooled and concentrated
using a 3000 MW cut off VIVASPIN 500 centrifugal filters (Sartorius
Stedim, Bohemia, NY) according to manufacturer’s instructions.
Concentrated albumin and globulin free fractions corresponding to
5 l of original plasma were used for Western blotting as described
above.
2.4. Semi-quantitative RT-PCR analysis of liver tissue
Frozen mouse liver tissue was  thawed and homogenized by
pipetting with 1 ml  of TRIzol reagent (Life Technologies, Grand
Island, NY). Total RNA was isolated according to manufacturer’s
protocol. For cDNA synthesis, total RNA (1 g) was subjected
to reverse transcription in a reaction mixture containing dNTPs
(0.5 mM),  random hexamer primer (0.01 g/l), and 40 U of RNase
inhibitor (Thermo Scientific, Waltham, MA)  and RNasin (Promega
Corporation, Madison, WI)  for 45 min  at 50 ◦C. Using premix PCR
mixture (Thermo Scientific, Waltham, MA), PCR was  performed in
the presence of 0.33 M of gene specific primers and 0.5 l of cDNA
in thermal cycler as follows; 95 ◦C × 1 min, followed by 35 cycles
of 95 ◦C × 30 s, 61 ◦C × 30 s, 72 ◦C × 30 s, subsequently 72 ◦C × 5 min.
Primers for GFAP were 5′-CTGGCTGCGTATAGACAGGA-3′ as for-
ward, 5′-GAACTGGATCTCCTCCTCCA-3′ as reverse, and primers
for Tau were 5′-GTGGAGGCAGTGTGCAAATA-3′ as forward, 5′-
GCCAATCTTCGACTGGACTC-3′ as reverse. Aliquots were loaded and
electrophoresed in 2% agarose gel. PCR product was visualized with
ethidium bromide under UV illuminator and the image was cap-
tured using GeneSnap software (Syngene, Frederick, MD). Brain
tissue from sham control mice was  used as positive control.
P. Arun et al. / Neuroscience Letters 552 (2013) 87– 91 89
Fig. 1. Western blot analysis of the cerebellum showing the immediate decrease and later increase in the levels of GFAP and Tau proteins after repeated blast exposures.
Representative blot from two  out of four animals in each group is presented. Densitometry analysis was carried out as described in Section 2. *p < 0.01 (n = 4).
2.5. Statistical analysis
Statistical analysis was carried out by analysis of variance
(ANOVA) using SAS software version 9.3. Values were expressed
as mean ± standard deviation (SD). A p value less than 0.01 was
considered significant.
3. Results
3.1. Changes in GFAP and total Tau protein expression in the
brain after blast exposure
Western blot analyses of the cerebellum revealed biphasic time-
dependent changes in the expression of both GFAP and total Tau
proteins after repeated blast exposures (Fig. 1). The levels of these
proteins decreased significantly at 6 h and increased appreciably
at 24 h after repeated blast exposures. Densitometry analysis indi-
cated that the ratios of GFAP to actin as well as total Tau to actin
were significantly reduced at 6 h and increased considerably at 24 h
after repeated blast exposures.
3.2. Levels of GFAP and total Tau proteins in the plasma after
blast exposure
Similar to the brain, biphasic changes in the levels of both GFAP
and total Tau proteins were recorded in the plasma after repeated
blast exposures (Fig. 2). Densitometry of the Western blot showed
that plasma levels of GFAP as well as total Tau proteins were sig-
nificantly reduced at 6 h and increased at 24 h after repeated blast
exposures.
3.3. Levels of GFAP and total Tau proteins in the liver and spleen
after blast exposure
GFAP and total Tau proteins were readily detected in the liver
and spleen of sham control mice. Densitometry analysis and the
ratios of GFAP to actin as well as total Tau protein to actin indicated a
significant increase in the levels of both GFAP and total Tau proteins
in the liver and spleen at 6 and 24 h after blast repeated exposures
(Fig. 3). Compared to 6 h, the increase in the levels of both GFAP
and total Tau proteins at 24 h was marginal and was not statistically
significant in both tissues.
3.4. Expression of GFAP and Tau mRNA levels in the liver after
blast exposure
To investigate whether the increase in GFAP and Tau proteins in
the liver is due to increased synthesis, RT-PCR of liver tissue mRNA
was performed and showed the presence of products with the same
base pairs corresponding to GFAP and Tau proteins in the brain.
Semi-quantitative RT-PCR analysis of liver tissues indicated that
the levels of GFAP or Tau mRNAs were not increased significantly
at 6 or 24 h after repeated blast exposures (Fig. 4).
4. Discussion
Our results showed for the first time that repeated blast expo-
sures caused pronounced biphasic changes in two well-known
biomarkers of TBI in the brain and plasma. In the brain and plasma,
the levels of GFAP and total Tau proteins decreased significantly
at 6 h after repeated blast exposures, whereas their levels were
increased at 24 h post-blast exposures. The increase in the expres-
sion of GFAP at 24 h after blast exposure is in agreement with the
previous preclinical studies [4,24]. To our knowledge, no studies
have established this acute change in GFAP in the brain or plasma
after single or repeated blast exposures. In the case of Tau pro-
tein, measured changes in total or phosphorylated Tau have been
restricted to several days after single blast exposure [7,10].
The significant decrease in GFAP and Tau proteins in the brain
at 6 h after repeated blast exposures was  an unanticipated and
somewhat paradoxical result. Since the turnover of GFAP and Tau
proteins in the brain is very slow [6,16], the acute decrease in
GFAP/Tau in the brain after blast exposure can most likely be inter-
preted as a blast-induced rapid disruption of glial/neuronal cell
membranes and protein leakage across a disrupted blood–brain
barrier into the circulation. However, Western blotting of plasma
showed a similar significant decrease in the levels of both the pro-
teins at 6 h after repeated blast exposures (Fig. 2). Parallel decreases
of both putative biomarkers in brain and plasma shortly after blast
exposure points to their rapid redistribution or elimination from
the blood during this acute timeframe.
Using an in vitro model of blast-induced TBI, it has recently
been shown that blast exposure causes transient disruption of neu-
ronal cell membrane integrity leading to bidirectional movement
of molecules across the cell membrane [1]. Rapid disruption of
cell membrane integrity of liver cells and muscle fibers and the
Fig. 2. Western blot analysis of plasma showing the immediate decrease and later increase in the levels of GFAP and Tau proteins after repeated blast exposures. Representative
blot  from two out of four animals in each group is presented. Densitometry analysis was carried out as described in Section 2.*p < 0.01 (n = 4).
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Fig. 3. Western blot analysis of liver (A) and spleen (B) showing the levels of GFAP and Tau proteins at 6 and 24 h after repeated blast exposures. Representative blots from
two  out of four animals in each group for liver and spleen are presented. Densitometry analysis was  carried out as described in Section 2.*p < 0.01 (n = 4).
Fig. 4. Semi-quantitative RT-PCR analysis of liver showing the mRNA levels of GFAP and Tau proteins. Total RNA isolated from the brain of a sham control mice was used as
positive  control. RT-PCR was carried out as described in the methods section. Representative figure from two out of four animals in each group is presented.
subsequent release of organ specific cellular proteins into the cir-
culation after repeated blast exposures have also been reported
[2]. Collectively, these data suggest that blast exposure affects the
cell membrane integrity of brain and peripheral organs which can
lead to widespread bidirectional passage of molecules. The vari-
ous potential mechanisms of cell membrane disruption after blast
exposure have been described in detail by Nakagawa et al. [18].
The parallel decreased levels of GFAP/Tau proteins in the brain
and plasma at 6 h after repeated blast exposures suggests a possi-
ble shift and accumulation of these proteins in peripheral organs.
Liver is one of the largest organs of the body and it showed blast
overpressure-dependent release of enzyme to circulation, revea-
ling cell membrane disruption [2]. Based upon earlier studies of
liver after blast exposure and the expression of GFAP and Tau pro-
teins in this organ [2,8,17], we investigated blast-induced changes
in the levels of these proteins in the liver. We  also examined the
spleen, which is a primary component of the reticuloendothelial
system where the blood is being processed. Increased levels of GFAP
and Tau in both the liver and spleen coincided with their simul-
taneously decreased levels in the brain and plasma at 6 h after
repeated blast exposures. To investigate whether their increased
levels resulted from locally increased synthesis, we  measured the
mRNA levels of GFAP and Tau proteins in the liver. The semi-
quantitative RT-PCR analysis data showed no significant increase
in the mRNA levels of GFAP and Tau proteins in the liver. These
data reinforce the conclusion that these proteins transiently accu-
mulate in these organs following passage from the circulation after
repeated blast exposures.
Although GFAP and Tau proteins remained elevated in the liver
and spleen after blast exposure, there was no significant difference
in the levels at 24 h compared to 6 h, even though the levels of these
proteins increased substantially in the plasma at 24 h after the blast
exposure. Restoration of vascular, liver, and spleen cell membrane
integrity may  have prevented further passage of these proteins in
these organs. Previous studies using in vitro and in vivo models of
blast-induced TBI indicate that the cell membrane disruption after
blast exposure is transient and the restoration of cell membrane
integrity take place rapidly [1,2].
A potential pathophysiological consequence of transient disrup-
tion of cell membrane integrity after blast exposure is the transport
of foreign molecules, including proteins, which can enter various
cells of peripheral organs and brain from the blood circulation
and may  remain intracellularly for longer time leading to chronic
pathological changes. Furthermore, the essential molecules rapidly
released from the cells due to transient disruption of cell mem-
brane after blast exposure can also affect cellular homeostasis.
Thus, the rapid abnormal bidirectional movement of molecules
in the brain and peripheral organs immediately after blast expo-
sure may  have the possibility to trigger long-term consequences,
a potential mechanism contributing to blast-induced polytrauma.
These time-dependent bidirectional changes also point to a fun-
damental issue complicating and potentially limiting the utility of
these circulating proteins as acute biomarkers of blast injury.
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